Overactive bladder pharmacotherapy: what does the future hold?
Dmochowski
Roger R
RR
Department of Urologic Surgery, Vanderbilt Continence Center, Vanderbilt University School of Medicine, Nashville, TN, USA. roger.dmochowski@vanderbilt.edu
D005260:Female; D005544:Forecasting; D006801:Humans; D008297:Male; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*; D014549:Urinary Incontinence / Q000188:drug therapy*; D014987:Xerostomia / Q000139:chemically induced
D018727:Muscarinic Antagonists